{"nct_id":"NCT00085904","title":"Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas","status":"COMPLETED","status_verified_date":"2008-10","start_date":"2004-04","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":null,"completion_date_type":null,"phases":["PHASE1"],"tickers":["GSK"]}